Cargando…
GNAO1 encephalopathy: Broadening the phenotype and evaluating treatment and outcome
OBJECTIVE: To describe better the motor phenotype, molecular genetic features, and clinical course of GNAO1-related disease. METHODS: We reviewed clinical information, video recordings, and neuroimaging of a newly identified cohort of 7 patients with de novo missense and splice site GNAO1 mutations,...
Autores principales: | Danti, Federica Rachele, Galosi, Serena, Romani, Marta, Montomoli, Martino, Carss, Keren J., Raymond, F. Lucy, Parrini, Elena, Bianchini, Claudia, McShane, Tony, Dale, Russell C., Mohammad, Shekeeb S., Shah, Ubaid, Mahant, Neil, Ng, Joanne, McTague, Amy, Samanta, Rajib, Vadlamani, Gayatri, Valente, Enza Maria, Leuzzi, Vincenzo, Kurian, Manju A., Guerrini, Renzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5362187/ https://www.ncbi.nlm.nih.gov/pubmed/28357411 http://dx.doi.org/10.1212/NXG.0000000000000143 |
Ejemplares similares
-
Phenotypic Assessment of Pathogenic Variants in GNAO1 and Response to Caffeine in C. elegans Models of the Disease
por: Di Rocco, Martina, et al.
Publicado: (2023) -
Not your grandma's stock market: the stock market has changed, and not for the better
por: McTague, Jim, et al.
Publicado: (2011) -
High frequency traders come out of the shadows
por: McTague, Jim, et al.
Publicado: (2011) -
Improving diagnosis and broadening the phenotypes in early-onset seizure and severe developmental delay disorders through gene panel analysis
por: Trump, Natalie, et al.
Publicado: (2016) -
Caenorhabditis elegans provides an efficient drug screening platform for GNAO1-related disorders and highlights the potential role of caffeine in controlling dyskinesia
por: Di Rocco, Martina, et al.
Publicado: (2021)